RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Abbott Laboratories

A collection of news and information related to Abbott Laboratories published by this site and its partners.

Top Abbott Laboratories Articles

Displaying items 13-24
  • Trail of stock deals led to DeCinces insider trading accusation

    Trail of stock deals led to DeCinces insider trading accusation
    The stock purchases began in December 2008, less than two months after discussions kicked off about the corporate acquisition of a California medical products manufacturer. By the time the deal was announced on Jan. 12, 2009, former Orioles third baseman...
  • In volatile market, some see bargains, others, pitfalls

    As the Dow took another 400-point tumble Thursday, Baltimore money manager David Stepherson found himself talking one client out of selling everything. "I advised him that it would not be a good idea because our view of things is that this is going to be...
  • Eddie Murray settles charges in insider trading probe

    Eddie Murray settles charges in insider trading probe
    Orioles Hall-of-Famer Eddie Murray has agreed to pay $358,151 to settle charges that he illegally profited from an insider trading scheme involving former teammate Doug DeCinces, the U.S. Securities and Exchange Commission announced Friday. Murray, who...
  • Lawmakers to re-examine tough inversion issue

    WASHINGTON Lawmakers are expected to return from their August recess with proposals to close a loophole that allows companies like Pennsylvania's Mylan Pharmaceuticals to avoid paying Uncle Sam by acquiring foreign competitors and reincorporating in...
  • P&G eyes Duracell, Braun in sweeping brand culling: sources

    NEW YORK (Reuters) - Procter & Gamble Co is working with advisors including Goldman Sachs Group as the world's largest household products maker reviews up to 100 underperforming brands for potential divestiture, people familiar with the matter said....
  • Abbott wins $19.5 million contract to develop brain injury test

    Abbott wins $19.5 million contract to develop brain injury test
    Abbott Laboratories and the Defense Department on Monday said they have agreed to a multiyear collaboration to develop portable blood tests to help evaluate concussions and other head injuries. Lake County-based Abbott will receive $19.5 million over the...
  • Chicago health tech hub accepting applications, names leaders

    Chicago health tech hub accepting applications, names leaders
    Matter, a not-for-profit health tech hub in downtown Chicago slated to open in early 2015, on Tuesday named a chief executive and said it's taking applications for new tenants. “What's been missing here in this (health technology) community is a...
  • Close loopholes that let U.S. firms avoid taxes by using inversions

    Close loopholes that let U.S. firms avoid taxes by using inversions
    It's both endearing and infuriating to watch American corporate executives wring their hands about how the injustices of the U.S. tax code are forcing them — forcing them! — to reincorporate overseas through the procedure known as inversion....
  • Baxter has no plans for inversion with spinoff

     Baxter has no plans for inversion with spinoff
    While its peers in the northern suburbs and around the pharmaceutical industry have been lining up foreign mergers to help sidestep U.S. taxes, Baxter International said Thursday it has no plans to jump on the bandwagon. The Deerfield-based health...
  • AbbVie to buy Shire in $55-billion deal that slashes tax rate

    AbbVie to buy Shire in $55-billion deal that slashes tax rate
    Illinois drug maker AbbVie Inc. said Friday it would buy European rival Shire for $55 billion and reincorporate in Britain, allowing the company to slash its tax rate in the latest move by an American firm to shelter its foreign earnings. The deal...
  • AbbVie to Buy Shire for $54.8 billion in biggest inversion

    AbbVie to Buy Shire for $54.8 billion in biggest inversion
    AbbVie Inc. is buying Shire for nearly $55 billion, the largest deal in a year filled with merger and acquisition activity, and the latest example of companies taking foreign addresses to cut taxes. The deal will allow North Chicago-based pharmaceutical...
  • Abbott beats 2Q profit forecast

    Abbott beats 2Q profit forecast
    Abbott Laboratories Inc reported better-than-expected quarterly earnings on Wednesday as demand for its recently-recalled infant formulas began to recover and profit margins improved for other business segments. Sales of nutritional products, the...